SEC Form 4 · accession 0002048497-26-000008
Beta Bionics, Inc. · BBNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hopman
Officer — Chief Commercial Officer
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 6:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001674632
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | S | 275 | $12.31 | D | 130,612 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.